Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82 Leukemia, Myeloid, Chronic-Phase 22 Leukemia 21 Gastrointestinal Stromal Tumors 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Neoplasms 8 Blast Crisis 7 Neoplasm Metastasis 6 Philadelphia Chromosome 4 Myeloproliferative Disorders 4 Melanoma 4 Leukemia, Myeloid 4 Bone Marrow Diseases 4 Recurrence 3 Leukemia, Myeloid, Acute 3 Hematologic Diseases 3 Bronchiolitis Obliterans Syndrome 3 Synovitis, Pigmented Villonodular 2 Ovarian Neoplasms 2 Neoplasm, Residual 2 Leukemia, Myeloid, Accelerated Phase 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Substance Withdrawal Syndrome 1 Sarcoma 1 Retroperitoneal liposarcoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Piebaldism 1 Peritoneal Neoplasms 1 Neurofibromatoses 1

Interventions

Fluorouracil 218 Leucovorin 201 Oxaliplatin 191 Irinotecan 148 Bevacizumab 107 Capecitabine 93 Cetuximab 89 Folfox protocol 54 Chemotherapy, Adjuvant 34 Panitumumab 30 pembrolizumab 23 Nivolumab 22 Colonoscopy 22 Gemcitabine 20 Magnetic Resonance Spectroscopy 19 Floxuridine 19 IFL protocol 18 Celecoxib 18 Radiotherapy 17 Neoadjuvant Therapy 17 Early Intervention, Educational 17 Drug Therapy 17 Laparoscopy 14 Cyclophosphamide 14 Counseling 14 trifluridine tipiracil drug combination 13 regorafenib 13 XELOX 13 Exercise 13 Erlotinib Hydrochloride 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Colonic Neoplasms × nilotinib × Clear all

NCT02774512 2017-10-06

ZAK-0

Institut Bergonié

Phase EARLY_PHASE1 Withdrawn

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡